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Abstract
TRPM6 and TRPM7 are bifunctional proteins expressing a TRP channel fused to an atypical a-kinase domain. While the
gating properties of TRPM6 and TRPM7 channels have been studied in detail, little is known about the mechanisms
regulating kinase activity. Recently, we found that TRPM7 associates with its substrate myosin II via a kinase-dependent
mechanism suggesting a role for autophosphorylation in substrate recognition. Here, we demonstrate that the cytosolic C-
terminus of TRPM7 undergoes massive autophosphorylation (3264 mol/mol), which strongly increases the rate of substrate
phosphorylation. Phosphomapping by mass spectrometry indicates that the majority of autophosphorylation sites (37 out
of 46) map to a Ser/Thr-rich region immediately N-terminal of the catalytic domain. Deletion of this region prevents
substrate phosphorylation without affecting intrinsic catalytic activity suggesting that the Ser/Thr-rich domain contributes
to substrate recognition. Surprisingly, the TRPM6-kinase is regulated by an analogous mechanism despite a lack of
sequence conservation with the TRPM7 Ser/Thr-rich domain. In conclusion, our findings support a model where massive
autophosphorylation outside the catalytic domain of TRPM6 and TRPM7 may facilitate kinase-substrate interactions leading
to enhanced phosphorylation of those substrates.
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Introduction
The channel-kinases TRPM6 and TRPM7 are bifunctional
proteins consisting of a TRP cation channel fused to a kinase and
represent the only two proteins in the mammalian genome with
this particular architecture [1,2]. A critical issue in understanding
these intriguing proteins is to identify the molecular mechanisms
controlling the activation of the channel as well as kinase activity
and establish the functional link between these two domains.
Within only a few years, major advances have been made in our
understanding of the role and regulation of TRPM6 and TRPM7
channels. Genetic and electrophysiological studies have identified
a major role for TRPM6 and TRPM7 in Mg2+ homeostasis. Both
TRPM6 and TRPM7 channels permeate divalent cations
including Mg2+ [3–5]. Mutations in TRPM6 cause the disease
familial hypomagnesemia with secondary hypocalcemia [6,7]
whereas ablation of TRPM7 in DT-40B cells leads to growth
arrest as the cells become hypomagnesic [8]. Importantly, these
phenotypes can be rescued by supplementing the patient’s diet or
growth media with Mg2+ [6–8]. However, recent evidence suggests
additional cellular roles for TRPM6 and TRPM7. For instance,
TRPM7 has been implicated in various cellular functions, many of
which are dependent on Ca2+-influx, including cell proliferation,
anoxic cell death, exocytosis, mechanotransduction, actomyosin
contractility and cell adhesion [3,8–15].
The principal feature of TRPM6 and TRPM7 channels, which
distinguishes them from other TRP channels, is their sensitivity to
physiological Mg2+ and Mg2+-nucleotide concentrations [3,5,16].
These channels are activated upon depletion of Mg2+ ions in cells
and native TRPM7-like currents have been called magnesium
inhibited cation (MIC) or magnesium-nucleotide regulated metal
ion (MagNuM) currents [3,17]. This property suggested a role for
the kinase in regulating the gating of these channels. However, it
has become evident that catalytic activity is not required for
TRPM7 channel opening although the kinase domain may govern
the set point for Mg2+ sensitivity [8,18,19]. We and others have
found that TRPM7 channels are also regulated by receptor-
mediated signaling [20–22]. While the function and regulation of
TRPM6 and TRPM7 channels have been extensively studied,
little is known about the molecular mechanisms activating their
kinase moieties.
TRPM6 and TRPM7 are members of a novel family of atypical
protein kinases called a-kinases [23,24]. These kinases display little
sequence similarity with conventional protein kinases (CPK).
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Moreover, a-kinases can be further distinguished from CPK by
their substrate specificity. While CPK phosphorylate amino acids
found in irregular structures as well as turns and loops [25], a-
kinases are thought to predominantly phosphorylate residues
present in a-helices [26]. Despite these differences, the topology of
the a-kinase domain is very similar to that of CPK [27].
Like CPK, TRPM6 and TRPM7 undergo autophosphorylation
[18,28,29] but the functional consequences for catalytic activity
are unknown. Recently, we demonstrated that the interaction
between TRPM7 and the actomyosin cytoskeleton is dependent
on kinase activity, suggesting a role for autophosphorylation in the
recognition of its substrates including myosin II [10]. Therefore,
we further investigated the role of autophosphorylation in
regulating the activity of the mammalian a-kinases TRPM6 and
TRPM7.
Results
TRPM7 undergoes massive autophosphorylation of its C-
terminus
To test the role of autophosphorylation in modulating the kinase
activity of TRPM7, the cytosolic C-terminal tail of TRPM7
(TRPM7-C-long; aa 1158–1864; Fig. 1) was purified from
mammalian cells and subjected to in vitro kinase assays.
Remarkably, incubation of TRPM7 with ATP in vitro led to the
incorporation of 3264 mol of phosphate per mol of kinase which
was accompanied by a dramatic shift in electrophoretic mobility
on SDS-PAGE gels (Fig. 2A). The non-phosphorylated protein,
which migrates at around 80 kDa, shows an apparent molecular
mass of 120 kDa after in vitro kinase assays. The change in
electrophoretic mobility is due to autophosphorylation because
incubation of a catalytically inactive mutant with ATP had no
effect on the migratory behavior of TRPM7-C-long. The kinetics
of TRPM7-C-long autophosphorylation demonstrates that this
process is very rapid. Autophosphorylation was detectable within
10 s and reached completion within 2-5 min (Fig. 2B). Moreover,
autophosphorylation of TRPM7-C-long proceeds via multiple
intermediate phosphorylation states as depicted by the gradual
change in electrophoretic mobility of TRPM7. These results
demonstrate that TRPM7 massively phosphorylates its cytosolic
C-terminal tail via a multi-step process.
The change in electrophoretic mobility of TRPM7
correlates with its ability to phosphorylate exogenous
substrates
The degree of TRPM7 autophosphorylation depends on ATP
concentration (Fig. 3). Titration of ATP demonstrated that
TRPM7-C-long undergoes complete autophosphorylation at
concentrations ranging between 10 and 500 mM when using
Mn2+ as cofactor. Notably, the phosphorylation of myosin II was
optimal at those ATP concentrations that led to complete
autophosphorylation of TRPM7-C-long (Fig. 3A). Even at very
high [c-32P]ATP specific activities, phosphorylation of myosin II
was not observed when ATP concentrations were below a certain
threshold (10 mM) (Fig. 3B). In contrast, TRPM7-C-long autopho-
sphorylation was easily detected at these low ATP concentrations
(Fig. 3B). When comparing the kinetics of kinase versus substrate
phosphorylation, we observed that the onset of myosin II
phosphorylation occurs when TRPM7 autophosphorylation is
complete (Fig. 4). Again, TRPM7-C-long autophosphorylation
reached maximum after about 5 min. In contrast, myosin II
phosphorylation was only measurable after 5 min and increased
throughout the experiment, which was stopped at the 30 min
Figure 1. Schematic diagram depicting the constructs of
TRPM6 and TRPM7 used in the current investigation. TRPM6
and TRPM7 encode both a channel (black) and an a-kinase domain
(grey). The typical TRP domain (stripes) is present directly C-terminal to
the last transmembrane domain and a Ser/Thr-rich region (checkered) is
present immediately N-terminal of the kinase domain. In addition to the
full-length protein, the entire cytosolic C tail but excluding the TRP
domain of TRPM6 and TRPM7 (TRPM6-C-long and TRPM7-C-long) as
well as the isolated kinase domain of TRPM7 (TRPM7-C-short) were
expressed as HA-tagged recombinant proteins in mammalian cells.
Mouse and human TRPM7 sequences found in the NCBI database differ
by a single amino acid. Since we used human TRPM7 in this study, we
have corrected all positions to correspond to the human sequence and
therefore Ser1511 and Ser1567 become Ser1512 and Ser1568,
respectively.
doi:10.1371/journal.pone.0001876.g001
Figure 2. TRPM7 undergoes extensive autophosphorylation of
the C-terminus via a sequential series of phosphorylation
events. (A) Autophosphorylation of TRPM7 dramatically reduces its
electrophoretic mobility. WT and KD TRPM7-C-long were incubated in
the absence or presence of MnATP for 30 min and detected using anti-
HA (top panel) and anti-pThr antibodies (bottom panel). (B) Kinetics of
TRPM7 autophosphorylation. TRPM7-C-long was incubated with MnATP
for the indicated times. Proteins were detected by immunoblotting
using anti-HA antibodies.
doi:10.1371/journal.pone.0001876.g002
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mark. These results indicate that TRPM7 autophosphorylation
facilitates the subsequent phosphorylation of exogenous substrates.
TRPM7 autophosphorylation accentuates the kinetics of
substrate phosphorylation
To show that autophosphorylation regulates TRPM7 kinase
activity towards its substrates, we compared the rate of myosin II
phosphorylation by TRPM7-C-long before and after treatment
with ATP (Fig. 5). In this classical experimental design, it is
predicted that the phosphorylated kinase will phosphorylate its
substrates more rapidly than the nonphosphorylated kinase if
autophosphorylation is a key event in activating the protein kinase.
The reason for the difference in kinetics is that the kinase pre-
treated with ATP will be able to directly phosphorylate its
substrates whereas the nonphosphorylated kinase will first need to
undergo autophosphorylation. Here, we show that pre-treatment
of TRPM7-C-long with ATP led to a significant increase in the
kinetics of myosin II phosphorylation (Fig. 5A,B). Suddenly,
phosphorylation of myosin II was detectable within 10 s and
increased steadily in the first 5 min, which is a time scale where no
to little myosin II phosphorylation was detected if TRPM7-C-long
was not previously incubated with ATP. TRPM7 requires
approximately 5 min to complete autophosphorylation (Fig. 4)
and after this time point, myosin II phosphorylation will proceed
at the same rate in both samples explaining the detection of
significant myosin II phosphorylation at later time points. In
contrast, phosphorylation-kinetics of the artificial substrate MBP
were not affected by prior treatment of TRPM7 with ATP as
previously described [29] (Fig. 5C,D). These results demonstrate
that TRPM7 autophosphorylation facilitates kinase activity
towards exogeneous substrates such as myosin II without affecting
intrinsic catalytic activity.
Massive autophosphorylation of the Ser/Thr-rich domain
(aa 1380–1548) controls substrate phosphorylation
To address the mechanism by which autophosphorylation
affects TRPM7 kinase activity, we first mapped the phosphory-
lation sites by nano liquid chromatography tandem mass
spectrometry (LC-MS/MS) using a LTQ-FT mass spectrometer
according to a recent algorithm for post-translational modification
scoring from Olsen and colleagues [30]. To discriminate between
the residues phosphorylated by exogenous kinases and TRPM7
itself, a catalytically inactive mutant of TRPM7-C-long was also
analyzed in these experiments. Our data identify 49 phosphory-
lation sites of which 3 were also found in the kinase-dead (KD)
mutant (Fig. 6 and Suppl. Table S1). Thus we have identified 46
TRPM7 autophosphorylation sites and 3 sites targeted by other
protein kinases. Moreover, many of the novel TRPM7 autopho-
sphorylation sites are phosphorylated in vivo demonstrating the
physiological relevance of the identified sites (Fig. 6B). It should be
noted however that these sites are probably substoichiometrically
phosphorylated in vivo and further phosphorylated when TRPM7
is incubated with ATP in vitro. Although autophosphorylation sites
are present throughout the entire C-terminal tail, the majority of
these sites are concentrated in the Ser/Thr-rich region directly
adjacent to the catalytic domain (1380–1585). We therefore
hypothesized that this region could be an important regulatory
domain.
Figure 3. Onset of substrate phosphorylation occurs after
completion of TRPM7 autophosphorylation. (A) Effect of reducing
ATP concentration on TRPM7 autophosphorylation and myosin II
phosphorylation. TRPM7-C-long was incubated with GST-myosin IIA in
the presence of varying MnATP concentrations for 30 min at 30uC. The
specific activity of ATP was maintained constant for all samples. The
proteins were separated by SDS-PAGE, stained with coomassie brilliant
blue (bottom panel) and phosphorylated proteins were detected by
autoradiography (top panel). (B) Myosin II phosphorylation correlates
with TRPM7 autophosphorylation even at exceedingly high specific
activities. The experiment was performed as described in A except that
the specific activity of the ATP solution was varied to detect myosin II
phosphorylation at low ATP concentrations. All samples contained
5 mCi of [c232P]-ATP supplemented with the indicated concentrations
of cold ATP.
doi:10.1371/journal.pone.0001876.g003
Figure 4. TRPM7 autophosphorylation precedes phosphoryla-
tion of substrates. TRPM7-C-long was incubated with GST-myosin IIB
in the presence of Mn[c232P]-ATP for the indicated times. The proteins
were separated by SDS-PAGE, revealed by coommassie staining
(bottom panel) and phosphorylated proteins were detected by
autoradiography (top panel).
doi:10.1371/journal.pone.0001876.g004
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We investigated the contribution of this Ser/Thr-rich domain to
TRPM7 kinase activity by generating a construct (TRPM7-C-
short) containing only the catalytic domain plus a small extension
(40 aa) that is required for dimerization. TRPM7-C-short
autophosphorylated itself leading to the incorporation of approx-
imately 4 times less phosphate than TRPM7-C-long. However in
contrast to TRPM7-C-long, the electrophoretic mobility of
TRPM7-C-short did not change significantly (Fig. 7A). Strikingly,
phosphorylation of myosin II by TRPM7 was greatly reduced
when the regulatory domain was deleted (Fig. 7B, Suppl. Fig. S1).
The level of myosin II phosphorylation was only 5% of the levels
achieved when using TRPM7-C-long in in vitro kinase reactions
(Fig. 7C) despite TRPM7-C-short having similar catalytic activity
in comparison to TRPM7-C-long (Fig. 7D). Removal of a more
upstream region (aa 1158 to 1380) led to a kinase that underwent
extensive electrophoretic mobility shift and could phosphorylate
myosin II to similar degree as the TRPM7-C-long kinase
(unpublished data). Thus, the autophosphorylation sites concen-
trated in the Ser/Thr-rich domain are responsible for the
electrophoretic mobility shift and required for efficient phosphor-
ylation of substrates but dispensable for catalytic activity.
Despite a lack of sequence conservation, TRPM6 is also
regulated by autophosphorylation of the Ser/Thr-rich
domain
Alignment of the TRPM6 and TRPM7 sequences reveals that
the protein is highly conserved throughout the molecule except in
the region between the TRP and kinase domains of the C-terminal
tail (Fig. 8A). Since this region regulates substrate recognition by
TRPM7, we investigated whether it has a similar role in
controlling TRPM6 kinase activity. Incubation of TRPM6-C-
long with ATP led to a noticeable shift in electrophoretic mobility
on SDS-PAGE gels (Fig. 8B). The kinetics of autophosphorylation
of TRPM6-C-long also preceeded the phosphorylation of myosin
II (Fig. 8C). Moreover, pre-incubation of TRPM6-C-long with
ATP increased the rate of myosin II phosphorylation indicating
that TRPM6 is activated by autophosphorylation (Fig. 8D).
Despite the lack of sequence homology between TRPM6 and
TRPM7, autophosphorylation also occurs in the region immedi-
ately upstream of the kinase (data not shown). Accordingly, this
domain is serine and threonine-rich in both kinases. We conclude
that although the regulatory domains of TRPM6 and TRPM7
show little similarity at the amino acid level, these sequences are
essential for substrate phosphorylation by both kinases.
Discussion
TRPM6 and TRPM7 play a key role in Mg2+-homeostasis [6–
8]. In addition, TRPM7 has been implicated in other cellular
processes including exocytosis, actomyosin contractility and cell
adhesion [11]. The role of TRPM6 and TRPM7 kinase activity
during these processes is largely unknown but experimental
evidence has clearly demonstrated that it is dispensable for
channel activation [18,19]. Instead, the catalytic activity of
Figure 5. Autophosphorylation of TRPM7 accelerates susbtrate phosphorylation without affecting catalytic activity. (A) Kinetics of
myosin II phosphorylation by TRPM7 prior to and after autophosphorylation. TRPM7-C-long was incubated in the absence (2ATP) or presence (+ATP)
of cold MnATP to generate non-phosphorylated and completely autophosphorylated TRPM7. ATP was subsequently removed by washing the kinase
with in vitro kinase buffer lacking ATP. Kinase reactions were initiated by adding Mn[c232P]-ATP and GST-myosin IIB and allowed to proceed at 30uC
for the indicated times. Proteins were resolved by SDS-PAGE and visualized by coomassie staining (bottom panel). Phosphorylated myosin II (top
panel) was detected by autoradiography. Note that the kinase pre-incubated in buffer without ATP (2ATP) must first complete autophosphorylation
(5 min), apparent from the reduced electrophoretic mobility shift of TRPM7 (refer to Fig. 4), to acquire the ability to phosphorylate its substrates. (B)
Quantification of myosin II phosphorylation by TRPM7 pre-incubated in absence (2ATP) or presence (+ATP) of ATP. 32P incorporation was measured
by phosphorimaging analysis. The phosphorylation levels measured for myosin incubated for 30 min with TRPM7 that was pre-incubated with ATP
was set to 1 and all other values are reported relative to that sample. (C) TRPM7 autophosphorylation does not affect catalytic activity. Experiment
was performed as described in part A but using MBP as substrate. (D) Quantification of MBP phosphorylation by TRPM7 pre-incubated in absence
(2ATP) or presence (+ATP) of ATP. Data was derived as described in part B.
doi:10.1371/journal.pone.0001876.g005
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TRPM6 and TRPM7 kinases is most likely required for the
phosphorylation of downstream targets such as annexin I and
myosin II [10,31]. Our work now demonstrates a vital role for
autophosphorylation of the Ser/Thr-rich domain in controlling
the protein kinase activity of TRPM6 and TRPM7 towards their
substrates. This investigation provides the first account of a mode
of activation for the mammalian a-kinases TRPM6 and TRPM7
which will help refine current models and develop new ones as to
how TRPM6 and TRPM7 function during health and disease.
How does autophosphorylation of the Ser/Thr-rich region affect
the protein kinase activity of TRPM6 and TRPM7? Our data
clearly demonstrate that in the absence of autophosphorylation or
the Ser/Thr-rich domain, the phosphorylation of protein
substrates by TRPM6 and TRPM7 is inefficient despite the
kinase having full enzymatic activity. Thus, autophosphorylation
of the Ser/Thr-rich region does not enhance enzymatic activity
but provides access of the catalytic domain to the substrate. The
simplest mechanistic explanation for this process is that substrate
recognition occurs through a direct interaction between the
hyperphosphorylated Ser/Thr-rich region and substrate. Unfor-
tunately, the high salt conditions required to maintain myosin II
filaments in a non-aggregated state in vitro, do not allow us to study
direct interactions between hyperphosphorylated TRPM7 and
myosin II. However, in support of this model, we have
Figure 6. Identification of phosphorylated residues in TRPM7 by LC-MS/MS. WT and KD TRPM7-C-long were incubated in the presence of
MnATP for 0 or 30 min. Tryptic peptides were analyzed using LTQ-FT mass spectrometer. (A) Representative MS2 and MS3 spectra for a TRPM7
peptide phosphorylated on Ser-1614. (m/z observed of parent ion was 823.3848, mass accuracy 1.85 ppm, +2 charge state; NL indicates neutral loss
of H3PO4 which triggers acquisition of MS
3 spectrum). The b+-ion series is indicated in red whereas the y+-ion series is in blue. S* refers to
dehydroserine. (B) Diagram depicting the phosphorylated residues identified in WT (red) and KD (blue) TRPM7-C-long incubated in presence (right) or
absence (left) of ATP.
doi:10.1371/journal.pone.0001876.g006
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demonstrated that several residues in the Ser/Thr-rich domain are
phosphorylated in vivo and that the association of TRPM7 with
myosin II in mammalian cells requires kinase activity [10].
Alternatively, hyperphosphorylation of the Ser/Thr-rich region is
predicted to cause dramatic changes in the 3D structure of
TRPM6 and TRPM7, which may promote a conformation more
apt for the phosphorylation of protein substrates. Current efforts
are aimed at understanding the molecular mechanisms by which
hyperphosphorylation of the Ser/Thr-rich domain elevates
substrate phosphorylation.
Although TRPM6 and TRPM7 are highly homologous proteins
(50% identity; 64% similarity), remarkably the Ser/Thr-rich
domain is poorly conserved at the amino acid level. Yet TRPM6
also requires massive autophosphorylation of the Ser/Thr-rich
region for efficient substrate phosphorylation. From these results,
we conclude that the build-up of negative charge in response to
hyperphosphorylation is the defining property rather than the
primary structure of the protein. In an attempt to further examine
this notion, we varied the salt concentration in the kinase
reactions. It is predicted that if the negative charge is an important
characteristic of the hyperphosphorylated kinase then counteract-
ing this charge by adding sodium ions should interfere with protein
phosphorylation. Indeed, we noticed that the addition of salt
inhibited the ability of TRPM7-C-long to phosphorylate myosin II
but it had no effect on autophosphorylation (Suppl. Fig. S2A, B).
The differences in the degree of TRPM7-mediated phosphoryla-
tion of itself and myosin II in presence of salt is not due to different
modes of catalysis (intra- vs. intermolecular) since intermolecular
autophosphorylation of TRPM7 appears to be independent of salt
or the presence of the regulatory domain (Suppl. Fig. S2C). These
data further strengthen the notion that the role of hyperpho-
sphorylation of the Ser/Thr-rich region is to allow access of the
catalytic domain to the substrate and moreover, that this process
requires the build-up of negative charge. Notably, the region of the
coiled-coil domain of myosin II that is phosphorylated by TRPM7
is positively charged. Thus, we speculate that electrostatic
interactions between the hyperphosphorylated Ser/Thr-rich
domain and myosin II are established to enhance substrate
phosphorylation or provide substrate specificity in vivo. Although
we cannot exclude other effects of salt within the kinase reactions
such as effects on substrate rather than kinase, this salt dependency
should be further explored to assess the role of massive autopho-
sphorylation in regulating the kinase activity of TRPM6 and
TRPM7 towards their substrates.
One of the most surprising results of this investigation is the
unprecedented number of autophosphorylation sites in TRPM6
and TRPM7. By LC-MS/MS, we identified 46 residues phos-
phorylated in wild-type (WT) but not in a catalytically inactive
mutant of TRPM7 demonstrating that phosphorylation the result
of autophosphorylation. Moreover, hyperphosphorylation of
Figure 7. Deletion of the Ser/Thr-rich domain in TRPM7 reduces substrate phosphorylation. (A) Autophosphorylation of TRPM7-C-short
only leads to a minor change in electrophoretic mobility on SDS-PAGE gels. TRPM7-C-short and TRPM7-C-long were incubated in the absence or
presence of MnATP for 30 min at 30uC and subjected to immunoblotting using anti-HA antibodies. (B) TRPM7-C-short phosphorylates myosin II less
efficiently than TRPM7-C-long. (i) TRPM7-C-short and TRPM7-C-long were incubated with GST-myosin IIB in the presence of Mn[c232P]-ATP. The
proteins were separated by SDS-PAGE, revealed by coommassie staining (middle panel) and phosphorylated proteins were detected by
autoradiography (left panel). (ii) Equal amounts of each kinase was verified by Western blotting (right panel). (C) Quantification of myosin II
phosphorylation by TRPM7-C-short and TRPM7-C-long. 32P incorporation was measured by phosphorimaging analysis. The phosphorylation levels
measured for myosin II incubated with TRPM7-C-long was set to 1 and values obtained for TRPM7-C-short are reported relative to that value. (D)
Deletion of residues 1158-1548 does not affect catalytic activity. (i) TRPM7-C-long and TRPM7-C-short WT and KD were incubated with MH1 peptide
in presence of Mn[c232P]-ATP. The level of phosphorylation was measured by scintillation counting. Background activity as determined using the KD
mutant was substracted from the WT TRPM7 samples and catalytic activity was reported relative to that of TRPM7-C-long, which was set to 1. (ii)
Equal amounts of each kinase were verified by Western blotting.
doi:10.1371/journal.pone.0001876.g007
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TRPM7 appears to be a physiologically relevant process since
20 sites were phosphorylated in vivo. Our phosphomapping
experiments are consistent with the level of phosphate
incorporation into the kinase where 3264 mol of phosphate is
incorporated per mol of TRPM7. Moreover, we identified
previously reported sites of TRPM7 autophosphorylation
including Thr1482, Ser1512 and Ser1568 [18,32]. The
authenticity of the phosphorylation sites is further demonstrated
by the ratio of phosphorylated serine and threonine residues
and their distribution within TRPM7. Phosphoamino acid
analysis of TRPM7 determined that phosphate is incorporated
70% into serines and 30% into threonines [28,32]. Accordingly,
we identify 31 serine and 15 threonine residues that are
phosphorylated by TRPM7. Moreover, these residues (37 out of
46) are predominantly located in the Ser/Thr-rich domain,
which is directly adjacent to the catalytic domain. Deletion of
this region leads to a corresponding 4-fold decrease in
phosphate incorporation into TRPM7. Others have also found
this region of TRPM6 and TRPM7 to be strongly autopho-
sphorylated [18,28]. In conclusion, our data convincingly show
the presence and identification of multiple TRPM6/TRPM7
autophosphorylation sites.
A major challenge is to identify residues essential for
TRPM6 and TRPM7 kinase activity. By deletion mapping,
we have determined that the Ser/Thr-rich region between
residues 1380 and 1548, which contains the greatest density of
autophosphorylation sites, is required for the electrophoretic
mobility shift and efficient phosphorylation of substrates. Howev-
er, we have yet to identify any priming event that would modulate
the extent of TRPM7 autophosphorylation, which is consistent
with a model where a build-up of negative charge is required for
substrate phosphorylation. Mutation of different residues to
alanine (Ser1512, Ser1568, Thr1686, Ser1694, Ser1780) either
individually or in combination did not suffice to affect TRPM7
autophosphorylation or activity towards myosin II (Suppl. Fig. S3).
Previously, Matsushita and colleagues reported that Ser1512 and
Ser1568 are the major sites of TRPM7 autophosphorylation [18].
Mutation of these residues to alanine led to a 90% decrease in
phosphate incorporation during in vitro kinase assays. This
discrepancy with our study may reflect differences in expression
systems. We have opted to purify TRPM7 directly from
mammalian cells whereas Matsushita et al. [18] produced TRPM7
in bacteria. A major problem with the purification of recombinant
proteins from prokaryotic cells is the reproducibility of the
specific activity of the enzyme. Unfortunately, Matsushita and
co-workers [18] did not provide evidence that catalytic activity of
the TRPM7 S1512A/S1568A double mutant was intact by
measuring the phosphorylation of a peptide substrate such as
MBP, which was previously shown to be independent of
autophosphorylation [29], nor did they confirm that mutation of
Ser1512 and Ser1568 was sufficient to abolish the incorporation
of 32P into TRPM7 in mammalian cells. In contrast, we have
Figure 8. Regulation of TRPM6 by autophosphorylation. (A) TRPM6 and TRPM7 display no sequence homology in the region spanning
between the TRP box and the kinase domain. Alignment of amino acid sequences of TRPM6 and TRPM7 using Blast-2-Blast from NCBI. The gap is a
result of low sequence similarity between the two proteins in the indicated region. (B) Autophosphorylation of TRPM6 leads to a dramatic shift in
electrophoretic mobility on SDS-PAGE gels. TRPM6-C-long and TRPM7-C-long were incubated in the absence or presence of MnATP, resolved by SDS-
PAGE and subsequently detected using anti-HA antibodies. (C) TRPM6 autophosphorylation precedes myosin II phosphorylation. TRPM6-C-long was
incubated with GST-myosin IIB in the presence of Mn[c232P]-ATP for the indicated times. The proteins were separated by SDS-PAGE, revealed by
coommassie staining (bottom panel) and phosphorylated proteins were detected by autoradiography (top panel). (D) Accelerated kinetics of myosin
II phosphorylation after pre-incubation of TRPM6 with ATP. TRPM6-C-long was incubated in the absence or presence of MnATP to generate non-
phosphorylated and completely autophosphorylated TRPM6. To initiate the phosphorylation of myosin II, in vitro kinase buffer containing Mn[c232P]-
ATP and GST-myosin IIB was added. The reaction was allowed to proceed at 30uC and stopped by adding Laemmli buffer after the indicated times.
Proteins were resolved by SDS-PAGE, visualized by coomassie staining (bottom panel) and phosphorylated proteins were detected by
autoradiography (top panel).
doi:10.1371/journal.pone.0001876.g008
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found many autophosphorylation sites of TRPM7 basally
phosphorylated in mammalian cells and in combination with
our in vitro analysis of TRPM7 mutants, it seems unlikely that the
TRPM7 S1512A/S1568A mutant would have significantly
reduced incorporation of phosphate in living cells. Although our
study raises doubts about the contribution of Ser1512 and Ser1568
to the capacity of TRPM7 to undergo autophosphorylation in
mammalian cells, it is plausible that an unknown factor in
mammalian cells may predispose TRPM7 to undergo massive
autophosphorylation despite the mutation of Ser1512 and Ser1568
to alanine. This factor could be an associated protein or
phosphorylation by upstream protein kinases. Indeed, we have
found 3 phosphorylation sites in a catalytically inactive mutant of
TRPM7 demonstrating the presence of protein kinases capable of
phosphorylating TRPM7. These sites are unlikely to be phos-
phorylated in bacterially-produced TRPM7 and therefore, may
regulate the extent of TRPM7 autophosphorylation. Clearly,
further studies are required to address the discrepancies between
our study and that of Matsushita and colleagues [18].
The molecular mechanism regulating the protein kinase activity
of TRPM6 and TRPM7 shows similarities but also important
differences with that of other a-kinases. The Dictyostelium myosin
heavy chain kinases (MHCK) A, B and C are all activated by
autophosphorylation [33–35]. The level of autophosphorylation
displays a wide dynamic range with stoichiometry of phosphoryla-
tion ranging from 6–20 mol Pi/ mol kinase [33,34,36]. However,
complete autophosphorylation does not appear to be required for
activation of MHC kinases since autophosphorylation of 3 sites (out
of 10) is sufficient to activate MHCKA [33] and myosin II
phosphorylation proceeds in parallel to MHCKC autophosphor-
ylation [34]. In contrast, TRPM6 and TRPM7 only phosphorylate
myosin II under conditions allowing complete autophosphorylation
of the kinases. Interestingly, eukaryotic elongation factor-2 (eEF-2)
kinase andMHCK, like TRPM7, require the presence of additional
regulatory domains for efficient substrate phosphorylation. In
contrast to TRPM6 and TRPM7 however, the regulatory domains
in eEF-2 kinase andMHCK are not subject to autophosphorylation
[36–38]. Similar to deletion of the Ser/Thr-rich domain of TRPM6
and TRPM7, removal of the regulatory domains in eEF-2 kinase
andMHCK decreases the rate of substrate phosphorylation without
affecting the kinetics of phosphorylation of a synthetic peptide [36–
39]. We therefore speculate that the Ser/Thr-rich domain has a
similar function to the regulatory domains found in other a-kinases
which play a key role in substrate recognition and that autopho-
sphorylation of this region provides an additional level of regulation
of TRPM6 and TRPM7 protein kinase activity.
In conclusion, we have identified a novel mechanism regulating the
activity of the mammalian a-kinases TRPM6 and TRPM7. Based on
the experimental evidence, we propose that massive autopho-
sphorylation of the Ser/Thr-rich domain in TRPM6 and TRPM7
provides an electrostatic interface for the recruitment of substrates
which greatly enhances their phosphorylation. Therefore, the protein
kinase activity of TRPM6 and TRPM7may impinge on their cellular
functions by controlling the recruitment of substrates in vivo through
hyperphosphorylation of the Ser/Thr-rich domain. Future experi-
ments should be aimed at revealing the structural changes that occur
in TRPM6 and TRPM7 after autophosphorylation and understand-
ing how these contribute to phosphorylation of substrates.
Materials and Methods
Constructs
To generate the different expression vectors encoding human
TRPM6 and TRPM7 kinase variants (Fig. 1), cDNA was
amplified by PCR using primers containing an HA-tag at the
59-end and inserted into pcDNA3 as a BamHI-NotI fragment. Point
mutations were introduced into TRPM7 by site-directed muta-
genesis using the Quikchange mutagenesis kit (Stratagene).
Human myosin IIA (aa 1795–1960) and IIB (aa 1802–1977)
heavy chain tails were amplified by PCR and inserted into the
BamHI-EcoRI sites in frame with GST in the pGEX-1N vector. All
constructs were verified by DNA sequencing.
Cell culture
HEK293 cells were cultured in DMEM medium with 10%
FCS. Cells were transfected using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s recommendations.
Purification of GST-myosin II and protein kinases
GST-myosin IIA and GST-myosin IIB were expressed in E. Coli
and purified by affinity chromatography on a glutathione-
sepharose column using standard methods. TRPM6 and TRPM7
kinases (Fig 1) were purified from mammalian cells by immuno-
precipitation. Cells were lysed in RIPA buffer and the kinases were
immunoprecipitated using anti-HA antibodies (12CA5) coupled to
protein G-sepharose.
In vitro kinase assays
Immunecomplexes containing 20 ng of kinase were washed and
resuspended in IVK buffer (50 mM HEPES pH 7.0, 4 mM
MnCl2, 2 mM DTT) with or without substrate. For protein
substrates, 2 mg of GST-myosin IIA, GST-myosin IIB or myelin
basic protein (MBP) were added to the reaction whereas the
peptide substrate MH1 (RKKFGESEKTKTKEFL) was present
at a concentration of 100 mM. The kinase reactions were initiated
by adding MnATP and were incubated at 30uC for the indicated
times. Kinase reactions containing recombinant proteins as
substrates were stopped by the addition of Laemmli buffer
containing 40 mM EDTA and subjected to SDS-PAGE. Proteins
were detected by immunoblotting using anti-HA (3F10, Roche) or
anti-phosphothreonine antibodies (Cell Signalling Technology) or
by autoradiography. Quantification was performed by phosphor-
imager analysis. Peptide substrates were spotted on p81 cellulose
paper and quantified by scintillation counting.
Mass Spectrometry
Phosphoproteins were separated by SDS-PAGE, stained with
colloidal coomassie blue and digested in-gel with trypsin using
standard protocols. Peptide identification experiments were
performed using a nano HPLC Agilent 1100 nano flow system
connected online to a 7-Tesla linear ion trap Ion Cyclotron
Resonance Fourier Transform (LTQ-FT) mass spectrometer
(Thermo Fisher, Bremen, Germany). Verification and site
mapping of phosphorylated peptides was perfomed according to
the procedure of Olsen and coworkers [30]. Phosphopeptides were
identified with a 99%-significance threshold when the sum of the
Mascot and PTM score was higher than 28 [30]. The delta PTM
score, the difference between the highest and second highest PTM
score, was set to be larger than 6.5 to exclusively report peptides
with a mapped phosphorylation site. Moreover, only phosphopep-
tides occurring more than once were included in the results.
Supporting Information
Table S1 TRPM7 phosphopeptides detected in WT and KD
TRPM7-C-long by LC-MS/MS.
Found at: doi:10.1371/journal.pone.0001876.s001 (0.20 MB
XLS)
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Figure S1 Autophosphorylation and substrate phosphorylation
by TRPM7-C-short is not due to a contaminating protein kinase.
WT and KD TRPM7-C-short were incubated with GST-myosin
IIB in presence of Mn[g-32P]-ATP. Proteins were separated by
SDS-PAGE and detected by coomassie staining (middle panel).
Phosphorylated proteins were revealed by autoradiography (top
panel). Equal amounts of WT and KD TRPM7-C-short was
verified by Western blotting (bottom panel).
Found at: doi:10.1371/journal.pone.0001876.s002 (0.33 MB TIF)
Figure S2 High ionic strength inhibits substrate phosphorylation
by TRPM7 without affecting catalytic activity. (A) Effect of salt on
TRPM7 and myosin II phosphorylation. TRPM7-C-long was
incubated with GST-myosin IIB and Mn[g-32P]-ATP in the
absence or presence of 250 mM NaCl for 30 min at 30uC. The
proteins were separated by SDS-PAGE, stained with coomassie
brilliant blue (bottom panel) and phosphorylated proteins were
detected by autoradiography (top panel). (B) Quantification of
TRPM7 and myosin II phosphorylation levels in absence and
presence of salt. 32P incorporation was measured by phosphor-
imaging analysis. The phosphorylation levels measured for the
sample containing no salt was set to 1 for each protein and values
obtained in presence of salt are reported relative to this value. (C)
Intermolecular autophosphorylation of TRPM7 is independent of
salt. Lysates of mammalian cells expressing WT TRPM7-C-short
were added to those of cells expressing KD TRPM7-C-long. The
proteins were co-purified by immunoprecipitation using anti-HA
antibodies. The beads were incubated with Mn[g-32P]-ATP for
30 min at 30uC in presence of 0 and 250 mM NaCl. Proteins were
separated by SDS-PAGE and phosphorylated proteins were
detected by autoradiography.
Found at: doi:10.1371/journal.pone.0001876.s003 (0.46 MB TIF)
Figure S3 Mutation of Ser1512, Ser1568, Thr1686, Ser1694 or
Ser1780 to alanine has no effect on TRPM7 autophosphorylation
or substrate phosphorylation. TRPM7-C-long constructs contain-
ing the point mutations S1512A, S1568A, T1686A, S1694A or
S1780A and the double mutants S1512A/S1568A and T1686A/
S1780A were immunoprecipitated from mammalian cells and
subjected to in vitro kinase assays. (A) Electrophoretic mobility
shift. After incubation in absence or presence of ATP, proteins
were subjected to immunoblotting using anti-HA antibodies. (B)
Phosphorylation of myosin II is unaffected by the different point
mutations. TRPM7-C-long was incubated with GST-myosin IIB
in presence of Mn[g-32P]-ATP. Proteins were separated by SDS-
PAGE and detected by coomassie staining (middle panel).
Phosphorylated proteins were revealed by autoradiography (top
panel). Equal amounts of WT and mutant TRPM7 kinase was
verified by Western blotting (bottom panel).
Found at: doi:10.1371/journal.pone.0001876.s004 (1.10 MB TIF)
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